Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Category Archive: Cancer stem cells
May 01
CD133+ Cancer Stem Cells Role in Metastasis
Excited for the 2nd publication this year through collaborative efforts with Harper Cancer Research Institute’s Karen Dahl (Title: CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche). I did the 3D confocal imaging that showed CD133+ ovarian cancer cells clearly penetrate the basal epithelial cells, pointing to metastatic potential of stem cell like cancer cells. Looking …
Apr 01
MRS 2018 Spring Symposium,
I will be at MRS 2018 from April 1 to April 5 presenting my work on novel cancer therapeutics Title: Biocompatible, Radiotherapeutic Hafnium Oxide Nanoparticle Imaging Probes Prepared Using a Novel Templated Synthesis Abstract Control ID: # 2884959 Paper # NM05.01.05 Presentation Date: April 2, 2018 Presentation Time: 9:30 AM to 9:45 AM Location: PCC …
Nov 05
Dual Mode CT/Fluorescence Detectable Immunotargeted Nanoparticle Probes to Identify Self-Renewing Cancer Cells In Vivo
Statement of Purpose: The high mortality and poor prognosis for women diagnosed with ovarian cancer is mainly due to late diagnosis. Improved detection of primary tumors and recurring tumors after chemotherapy is, therefore, crucial to reduce ovarian cancer mortality and improve progression-free survival. However, current clinical screening and diagnostic imaging methods are limited by low …
NIH Funding Opportunities
- Notice of Participation of NIMH in PAR-23-309 "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)" April 24, 2024Notice NOT-MH-24-245 from the NIH Guide for Grants and Contracts
- Request for Information (RFI) on the Use of In Vitro Lung Models in Inhalation Toxicology Research with Potential Application to Regulatory Decision-Making April 24, 2024Notice NOT-ES-24-007 from the NIH Guide for Grants and Contracts
- Notice of Special Interest (NOSI): Administrative Supplements for the Study of the Diverse Aspects of Uterine Serous Carcinoma (Clinical Trial Not Allowed) April 24, 2024Notice NOT-CA-24-044 from the NIH Guide for Grants and Contracts
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required) April 24, 2024Funding Opportunity PA-24-183 from the NIH Guide for Grants and Contracts. The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH […]
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) April 24, 2024Funding Opportunity PA-24-182 from the NIH Guide for Grants and Contracts. The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH […]
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) April 24, 2024Funding Opportunity PA-24-181 from the NIH Guide for Grants and Contracts. The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH […]
- NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) April 24, 2024Funding Opportunity PA-24-195 from the NIH Guide for Grants and Contracts. The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical […]
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) April 24, 2024Funding Opportunity PA-24-193 from the NIH Guide for Grants and Contracts. The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical […]
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) April 24, 2024Funding Opportunity PA-24-194 from the NIH Guide for Grants and Contracts. The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical […]
- Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required) April 24, 2024Funding Opportunity RFA-AG-25-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support a multi-center consortium that will function as a clinical trials network to collect safety and early efficacy data in defined groups of older adults with specific chronic pain conditions. This funding opportunity will use a […]
Recent Comments